Prestige Consumer Healthcare Inc (PBH) Expected to Announce Earnings of $0.80 Per Share

Equities research analysts expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will report earnings per share of $0.80 for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The highest EPS estimate is $0.80 and the lowest is $0.79. Prestige Consumer Healthcare reported earnings of $0.70 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 14.3%. The business is scheduled to report its next quarterly earnings report on Thursday, February 7th.

According to Zacks, analysts expect that Prestige Consumer Healthcare will report full year earnings of $2.88 per share for the current year, with EPS estimates ranging from $2.86 to $2.90. For the next financial year, analysts forecast that the company will report earnings of $3.04 per share, with EPS estimates ranging from $3.00 to $3.07. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, November 1st. The company reported $0.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The firm had revenue of $239.36 million for the quarter, compared to the consensus estimate of $236.28 million. During the same quarter last year, the business posted $0.61 EPS. The company’s revenue for the quarter was down 7.2% on a year-over-year basis.

Several analysts have issued reports on the company. Zacks Investment Research reissued a “hold” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, November 14th. DA Davidson lifted their target price on Prestige Consumer Healthcare to $38.00 and gave the company a “neutral” rating in a research report on Monday, November 5th. Finally, ValuEngine downgraded Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, November 16th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. Prestige Consumer Healthcare has an average rating of “Hold” and an average target price of $39.67.

PBH opened at $35.98 on Monday. Prestige Consumer Healthcare has a 1 year low of $27.84 and a 1 year high of $47.29. The stock has a market capitalization of $1.86 billion, a price-to-earnings ratio of 13.95, a PEG ratio of 1.78 and a beta of 1.01. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.38 and a current ratio of 2.15.

In related news, EVP Timothy Connors sold 34,000 shares of Prestige Consumer Healthcare stock in a transaction dated Monday, November 19th. The stock was sold at an average price of $38.25, for a total value of $1,300,500.00. Following the sale, the executive vice president now owns 25,775 shares of the company’s stock, valued at $985,893.75. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.14% of the stock is currently owned by insiders.

Large investors have recently added to or reduced their stakes in the stock. Bank of Montreal Can increased its position in shares of Prestige Consumer Healthcare by 135.9% in the second quarter. Bank of Montreal Can now owns 3,067 shares of the company’s stock valued at $118,000 after acquiring an additional 1,767 shares during the last quarter. Rehmann Capital Advisory Group increased its position in shares of Prestige Consumer Healthcare by 4,166.4% in the third quarter. Rehmann Capital Advisory Group now owns 5,077 shares of the company’s stock valued at $134,000 after acquiring an additional 4,958 shares during the last quarter. Zions Bancorporation acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter valued at about $137,000. Tower Research Capital LLC TRC increased its position in shares of Prestige Consumer Healthcare by 338.0% in the third quarter. Tower Research Capital LLC TRC now owns 3,754 shares of the company’s stock valued at $142,000 after acquiring an additional 2,897 shares during the last quarter. Finally, BlueMountain Capital Management LLC acquired a new stake in shares of Prestige Consumer Healthcare in the second quarter valued at about $208,000.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Further Reading: Why is insider trading harmful?

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit